Malaria Vaccine - What to Know About Life-Changing R21 PremiumTimesng: Nigeria
Like her West-African counterpart- Ghana, Nigeria on Monday made history with the approval granted a new malaria vaccine- R21/Matrix-M, which has been developed by theWith malaria accounting for 60 per cent of outpatient visits to the nation's health facilities; 30 per cent of childhood deaths; 11 per cent of maternal death, and 25 per cent of deaths in infants, Nigeria is said to contribute a huge 27 per cent to the global malaria burden.
But the latest intervention, according to the University of Oxford, a booster dose of the R21/Matrix-M vaccine at one year following a primary three-dose regime, maintained high efficacy against malaria and continued to meet the WHO's Malaria Vaccine Technology Roadmap goal of a vaccine with at least 75 per cent efficacy.
However, while the World Health Organisation is yet to give go-ahead for its roll-out, both Nigeria and Ghana's drug regulators have approved it domestically for children between the ages of five months and three years old.The R21/Matrix-M vaccine is said to target the plasmodium 'sporozoite', which is the first form of the malaria parasite entering the human body.
PREMIUM TIMES has reported that the Oxford team in collaboration with the Serum Institute of India will produce up to 200 million doses annually with a vaccine factory being constructed in Accra, Ghana.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Uganda: Vaccine Against Malaria in Children Gets ApprovalGhana on April 13 became the first country to approve public usage of a new experimental vaccine for children to protect them from malaria.
Read more »
Nigeria: Hope for Millions As Nigeria Approves Malaria VaccineSimilar to Ghana, Mrs Adeyeye said the vaccine is indicated for the prevention of malaria in children from 5 months to 36 months of age.
Read more »
Nigeria regulator grants approval to Oxford's malaria vaccineNigeria regulator grants approval to Oxford's malaria vaccine: Nigeria has granted provisional approval to Oxford University's R21 malaria vaccine, its medicines regulator said on Monday, making it the second country to do so after Ghana last week.
Read more »
Nigeria regulator grants approval to Oxford's malaria vaccineNigeria has granted provisional approval to Oxford University's R21 malaria vaccine, its medicines regulator said on Monday, making it the second country to do so after Ghana last week.
Read more »
Hope for Millions As Nigeria Approves Malaria VaccineNigeria has approved a new malaria vaccine developed by scientists at Oxford University, following Ghana's recent approval. The head of Nigeria's National Agency for Food and Drugs Administration, Mojisola Adeyeye, said the vaccine, known as R21, would be used for the prevention of malaria in children aged between five months and three years - the most vulnerable group. The approval is unique as it comes before the publication of final stage trial data, but it is believed to be 80% effective. Nigeria has the highest number of malaria deaths worldwide, with over 6,000 deaths annually, mostly affecting children in Sub-Saharan Africa.
Read more »
Markus Jooste trial in Germany - what you need to know | BusinessThe first criminal case against Markus Jooste (62), disgraced former CEO of Steinhoff, begins on Tuesday in Oldenburg, Germany. Here's everything you need to know. | News24_Business
Read more »